Marquette Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67K Sell
185
-93
-33% -$31.8K 0.01% 153
2026
Q1
$97.8K Buy
278
+24
+9% +$8.56K 0.01% 76
2025
Q4
$83.1K Sell
254
-61
-19% -$19.4K 0.01% 84
2025
Q3
$88.9K Buy
315
+58
+23% +$16.8K 0.01% 80
2025
Q2
$71.8K Hold
257
0.01% 82
2025
Q1
$80.1K Buy
257
+6
+2% +$1.77K 0.01% 85
2024
Q4
$65.4K Hold
251
0.01% 145
2024
Q3
$80.9K Sell
251
-10
-4% -$3.27K 0.01% 146
2024
Q2
$81.5K Hold
261
0.01% 122
2024
Q1
$74.2K Hold
261
0.01% 131
2023
Q4
$75.2K Hold
261
0.01% 130
2023
Q3
$70.1K Hold
261
0.02% 129
2023
Q2
$57.9K Hold
261
0.01% 141
2023
Q1
$63.1K Hold
261
0.02% 136
2022
Q4
$68.5K Hold
261
0.02% 142
2022
Q3
$59K Hold
261
0.02% 134
2022
Q2
$64K Sell
261
-4
-2% -$980 0.02% 151
2022
Q1
$64K Buy
+265
New +$60.9K 0.01% 176
2021
Q4
Sell
-17
Closed -$4K 261
2021
Q3
$4K Buy
+17
New +$3.91K ﹤0.01% 252
2019
Q2
Sell
-56
Closed -$11K 255
2019
Q1
$11K Buy
+56
New +$10.7K ﹤0.01% 239

Other funds holding AMGN

Marquette Asset Management's AMGN Position: Q2 2026 in Review

Marquette Asset Management reduced its Amgen (AMGN) stake by 33% in Q2 2026, selling an estimated $31.8K and leaving 185 shares worth $67K. The position accounts for 0.01% of the portfolio, ranked #153.

Marquette Asset Management first reported a position in AMGN in Q1 2019 and has held it in 20 quarters since. The position peaked at $97.8K in Q1 2026. 1,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marquette Asset Management held 185 shares of Amgen worth $67K as of Q2 2026.
  • Marquette Asset Management sold 93 Amgen shares in Q2 2026, an estimated $31.8K.
  • Amgen made up 0.01% of Marquette Asset Management's portfolio in Q2 2026, its #153 holding.
  • Marquette Asset Management first reported a position in Amgen in Q1 2019 and has held it in 20 quarters since.
  • Marquette Asset Management's Amgen position peaked at $97.8K in Q1 2026.
  • 1,195 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.